Search | IOVS | ARVO Journals

Showing 1 – 20 of 50

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Collaborative Ocular Oncology Group study 2 (COOG2): Prospective multi-center validation of the 15-gene expression profile (GEP)/PRAME molecular prognostic tool for uveal melanoma in 1586 patients

Zelia Correa; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4273.

ARVO Annual Meeting Abstract June 2024

Effect of BCOR loss in Xenopus laevis and tropicalis: Insights for retinal development

Samantha McLaughlin; Michelle Zhang; Dawn Owens; Nicole Jones; J William Harbour; Daniel Pelaez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):384.

ARVO Annual Meeting Abstract June 2022

Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

Usman Baqai; Timothy J Purwin; Vivian Chua; Anna Han; Nelisa Bechtel; Edward J. Hartsough; Jeffim Kuznetsoff; J. William Harbour; Andrew E. Aplin

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2364 – A0033.

ARVO Annual Meeting Abstract June 2022

Carboplatin Chemoresistance in Retinoblastoma

Michelle Zhang; Jeffim Kuznetsoff; Karthik Kalahasty; Daniel Pelaez; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2338 – A0007.

ARVO Annual Meeting Abstract June 2022

BAP1-mediated transcriptional influence on normal eye development

Christopher J Kaler; Daniel Rodriguez; Stefan Kurtenbach; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1891 – A0020.

ARVO Annual Meeting Abstract June 2021

Clinical characteristics and gene expression profile status in young patients with uveal melanoma: Collaborative Ocular Oncology Group study #2 (COOG2) study

Ekaterina Semenova; Christina Decatur; Amy C Schefler; Thomas Aaberg; Brian Marr; Zelia Correa; J. William Harbour; Prithvi Mruthyunjaya; Miguel Materin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):39.

ARVO Annual Meeting Abstract June 2021

Design, Methods, and Rationale for the Collaborative Ocular Oncology Group 2 (COOG2) Study

Amy C Schefler; Prithvi Mruthyunjaya; Christina Decatur; Miguel Materin; Zelia Correa; Thomas Aaberg; Brian Marr; Katya Semenova; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2870.

ARVO Annual Meeting Abstract June 2021

Deconvolution of tumor immune microenvironment in uveal melanoma

Anthony Cruz; Stefan Kurtenbach; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2874.

ARVO Annual Meeting Abstract June 2020

Aberrant expression of PROS1 as potential mechanism for macrophage dysfunction in BAP1-mutant Class 2 uveal melanoma

Christopher Joseph Kaler; Stefan Kurtenbach; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2844.

ARVO Annual Meeting Abstract June 2020

Interim analysis of small choroidal melanocytic tumors with and without identifiable driver mutations

Ezekiel Weis; Prithvi Mruthyunjaya; Amy C Schefler; Zelia Correa; Thomas M Aaberg; Michael Durante; Christina Decatur; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2847.

ARVO Annual Meeting Abstract June 2020

Lineage tracing in retinal organoids as a platform for studying retinoblastoma

Michelle G Zhang; Zenith Acosta Torres; Dawn Owens; Robert Suter; Nagi Ayad; J William Harbour; Daniel Pelaez

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3815.

ARVO Annual Meeting Abstract June 2020

Novel Long Non-Coding RNAs Associated with BAP1 Mutations in Uveal Melanoma

Daniel Rodriguez; Grant Gordan; Michael Durante; Jeffim Kuznetsov; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4023.

ARVO Annual Meeting Abstract July 2019

Addressing Disparities in Hispanic Patients with Uveal Melanoma Using Global and Local Ancestry Analysis

Daniel Rodriguez; Margaret I Sanchez; Christina Decatur; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):758.

ARVO Annual Meeting Abstract July 2019

Class 2 metastasizing uveal melanomas arise through BAP1 loss and epigenetic reprogramming to a migratory neural crest-like state

Matthew Field; Parker Bussies; Louie Cai; Christina Decatur; Jeffim Kuznetsov; Stefan Kurtenbach; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):957.

ARVO Annual Meeting Abstract July 2019

Metastatic Lesions to the Eye and Orbit: A 15-year Retrospective Review

Ann Quan; Sona Shah; Kara Marie Cavuoto, M.D.; Swarup S. Swaminathan; Armando Garcia; Thomas E Johnson; David T Tse; Wendy Lee; J. William Harbour; Sander Dubovy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3583.

Letters to the Editor October 2017

Letter to the Editor: Comparison of Alternative Tumor Size Classifications for Posterior Uveal Melanomas

PDF

J. William Harbour; Manuel Paez-Escamilla
TAGS: intraocular melanoma, tumor size
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5444. https://doi.org/10.1167/iovs.17-22603

ARVO Annual Meeting Abstract June 2017

Surgical approach and outcomes of pars plana vitrectomy in eyes harboring a treated posterior uveal melanoma

Nika Bagheri; Jorge Fortun; Justin H Townsend; Harry W Flynn; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5017.

ARVO Annual Meeting Abstract June 2015

Tumor diameter contributes prognostic information that enhances the accuracy of gene expression profile molecular classification in uveal melanoma

Scott Walter; Daniel L Chao; Joyce C Schiffman; William J Feuer; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4334.

ARVO Annual Meeting Abstract June 2015

Diffuse Intraocular Proliferation of uveal melanoma following radiotherapy

Amir Mohsenin; Vivek A. Rudrapatna; George J Harocopos; Sander R Dubovy; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5345.

Anatomy and Pathology/Oncology March 2015

Skewed Expression of the Genes Encoding Epigenetic Modifiers in High-Risk Uveal Melanoma

PDF

Naoimh Herlihy; Mehmet Dogrusöz; T. Huibertus van Essen; J. William Harbour; Pieter A. van der Velden; Marja C. J. A. van Eggermond; Geert W. Haasnoot; Peter J. van den Elsen; Martine J. Jager
TAGS: epigenetics, genes, intraocular melanoma, neoplasms, methylation
Invest. Ophthalmol. Vis. Sci.. 2015; 56(3):1447-1458. https://doi.org/10.1167/iovs.14-15250

Includes: Supplemental Content

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Collaborative Ocular Oncology Group study 2 (COOG2): Prospective multi-center validation of the 15-gene expression profile (GEP)/PRAME molecular prognostic tool for uveal melanoma in 1586 patients

Effect of BCOR loss in Xenopus laevis and tropicalis: Insights for retinal development

Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

Carboplatin Chemoresistance in Retinoblastoma

BAP1-mediated transcriptional influence on normal eye development

Clinical characteristics and gene expression profile status in young patients with uveal melanoma: Collaborative Ocular Oncology Group study #2 (COOG2) study

Design, Methods, and Rationale for the Collaborative Ocular Oncology Group 2 (COOG2) Study

Deconvolution of tumor immune microenvironment in uveal melanoma

Aberrant expression of PROS1 as potential mechanism for macrophage dysfunction in BAP1-mutant Class 2 uveal melanoma

Interim analysis of small choroidal melanocytic tumors with and without identifiable driver mutations

Lineage tracing in retinal organoids as a platform for studying retinoblastoma

Novel Long Non-Coding RNAs Associated with BAP1 Mutations in Uveal Melanoma

Addressing Disparities in Hispanic Patients with Uveal Melanoma Using Global and Local Ancestry Analysis

Class 2 metastasizing uveal melanomas arise through BAP1 loss and epigenetic reprogramming to a migratory neural crest-like state

Metastatic Lesions to the Eye and Orbit: A 15-year Retrospective Review

Letter to the Editor: Comparison of Alternative Tumor Size Classifications for Posterior Uveal Melanomas

Surgical approach and outcomes of pars plana vitrectomy in eyes harboring a treated posterior uveal melanoma

Tumor diameter contributes prognostic information that enhances the accuracy of gene expression profile molecular classification in uveal melanoma

Diffuse Intraocular Proliferation of uveal melanoma following radiotherapy

Skewed Expression of the Genes Encoding Epigenetic Modifiers in High-Risk Uveal Melanoma

To View More...

You must be signed into an individual account to use this feature.